Extensive Leptomeningeal Intracranial and Spinal Metastases in a Patient with a Supratentorial Glioblastoma Multiforme, IDH-Wildtype.

Schwartz, C; Romagna, A; Machegger, L; Weiss, L; Huemer, F; Fastner, G; Kleindienst, W; Serge, W; Greil, R; Winkler, PA; World Neurosurg. 2018; 120:442-447

Long-term trends in CD4 cell counts, CD8 cell counts, and the CD4: CD8 ratio: ART Cohort Collaboration (ART-CC) Study.

Hughes, RA; May, MT; Tilling, K; Taylor, N; Wittkop, L; Reiss, P; Gill, J; Schommers, P; Costagliola, D; Guest, JL; Lima, VD; Monforte, AD; Smith, C; Cavassini, M; Saag, M; Sterling, TR; Sterne, JAC; AIDS. 2018;

The multiple myeloma treatment landscape: international guideline recommendations and clinical practice in Europe.

Cavo, M; Terpos, E; Bargay, J; Einsele, H; Cavet, J; Greil, R; de Wit, E EXPERT REV HEMATOL. 2018; 11(3): 219-237.

Cure in metastatic breast cancer.

Westphal, T; Gampenrieder, SP; Rinnerthaler, G; Greil, R; Memo. 2018; 11(3):172-179

Time to repeal and replace response criteria for acute myeloid leukemia?

Bloomfield, CD; Estey, E; Pleyer, L; Schuh, AC; Stein, EM; Tallman, MS; Wei, A BLOOD REV. 2018; 32(5): 416-425.

A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc

Greil, R; Greil-Ressler, S; Weiss, L; Schönlieb, C; Magnes, T; Radl, B; Bolger, GT; Vcelar, B; Sordillo, PP; Cancer Chemother Pharmacol. 2018; 82(4): 695-706.

The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab.

Magnes, T; Melchardt, T; Hufnagl, C; Weiss, L; Mittermair, C; Neureiter, D; Klieser, E; Rinnerthaler, G; Roesch, S; Gaggl, A; Greil, R; Egle, A; Pharmacogenomics J. 2018; 18(3):-479

Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study.

Schommers, P; Gillor, D; Hentrich, M; Wyen, C; Wolf, T; Oette, M; Zoufaly, A; Wasmuth, JC; Bogner, JR; Müller, M; Esser, S; Schleicher, A; Jensen, B; Stoehr, A; Behrens, G; Schultze, A; Siehl, J; Thoden, J; Taylor, N; Hoffmann, C; Haematologica. 2018; 103(5): 857-864.

Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia.

Huemer, F; Weiss, L; Faber, V; Neureiter, D; Egle, A; Geissler, K; Voskova, D; Zebisch, A; Burgstaller, S; Pichler, A; Stauder, R; Sperr, W; Lang, A; Pfeilstöcker, M; Machherndl-Spandl, S; Stampfl, M; Greil, R; Pleyer, L; Wien Klin Wochenschr. 2018; 130(3-4): 115-125.

A prospective, multicenter pilot study to investigate the feasibility and safety of a 1-year controlled exercise training after adjuvant chemotherapy in colorectal cancer patients.

Piringer, G; Fridrik, M; Fridrik, A; Leiherer, A; Zabernigg, A; Greil, R; Eisterer, W; Tschmelitsch, J; Lang, A; Frantal, S; Burgstaller, S; Gnant, M; Thaler, J; Support Care Cancer. 2018; 26(4):1345-1352